サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1489208

凝固検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Coagulation Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
凝固検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年05月01日
発行: Value Market Research
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

凝固検査市場の世界需要は、2023年の28億2,000万米ドルから2032年には52億3,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2034年のCAGRは7.11%です。

凝固検査は、血液の凝固能を評価する診断プロセスです。凝固因子、血小板機能、凝固カスケード全体を測定するさまざまな臨床検査が含まれます。これらの検査は、出血性疾患、血栓症、肝疾患などの診断やモニタリングに役立ちます。一般的な検査には、プロトロンビン時間（PT）、活性化部分トロンボプラスチン時間（aPTT）、国際標準比（INR）、トロンビン時間（TT）などがあります。これらの検査結果は、抗凝固療法の管理、手術前の出血リスクの評価、凝固障害の診断のためにヘルスケアプロバイダーに貴重な情報を提供し、患者の最適なケアと治療成績に貢献します。

市場力学

血友病、血栓症、von Willebrand病などの凝固障害の有病率の増加は、心血管疾患、糖尿病、がんの急増と相まって、疾患の診断、モニタリング、管理の重要な要素として凝固検査の需要を促進しています。ヘルスケアプロバイダーが患者の治療と転帰の改善に努める中、凝固検査は出血および凝固障害の評価、治療方針の決定、血栓症や出血などの合併症の予防に極めて重要です。さらに、ポイントオブケア（POC）機器、検査室ベースの分析装置、分子アッセイなどの技術的進歩により、世界中の医療施設、診療所、検査室が正確でタイムリーな検査ソリューションを利用できるようになり、ヘルスケアの将来が有望視されています。

さらに、個別化医療アプローチや標的治療の採用が増加していることから、個別化治療戦略の指針となる迅速かつ正確な結果を提供する凝固検査アッセイに対する需要が高まっており、市場成長の原動力となっています。さらに、予防ヘルスケア、ウェルネス・スクリーニング、早期介入戦略を重視する傾向が強まっていることも、これらの検査を日常的な健康評価やウェルネス・プログラムに組み込む動きを後押ししており、市場拡大の原動力となっています。しかし、代替診断法の進歩やヘルスケア規制の変更が、今後数年間の市場成長の課題となる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは凝固検査の世界市場における各セグメントを包括的に評価することもできます。凝固検査業界の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける凝固検査市場の現在および将来の需要を明らかにする地域展望を取り上げます。さらに、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 凝固検査- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 凝固検査の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 実績データと予測データ
  • 製品タイプ別分析
  • 検査機器
  • 消耗品

第6章 凝固検査の世界市場分析：検査タイプ別

  • 検査タイプ別概要
  • 実績データと予測データ
  • 検査タイプ別分析
  • プロトロンビン時間（PT）
  • 活性化部分トロンボプラスチン凝固時間（APTT）
  • トロンビン時間（TT）
  • 活性化凝固時間（ACT）
  • その他

第7章 世界の凝固検査市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 病院およびクリニック
  • 診断研究所
  • 在宅医療
  • その他

第8章 凝固検査の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 凝固検査企業の競合情勢

  • 凝固検査市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Siemens Healthineers
  • Sysmex Corporation
  • Universal Biosensors Inc.
  • HemoSonics LLC
  • Thermo Fisher Scientific Inc.
  • Randox Laboratories Ltd.
  • Horiba Ltd.
  • Agappe Diagnostics Ltd.
  • Medtronic
  • Helena Laboratories Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Analysis By Test Type (USD MN)
  • Prothrombin Time (PT) Market Sales By Geography (USD MN)
  • Activated Partial Thromboplastin Clotting Time (APTT) Market Sales By Geography (USD MN)
  • Thrombin Time (TT) Market Sales By Geography (USD MN)
  • Activated Clotting Time (ACT) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Hospitals and Clinics Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Coagulation Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Coagulation Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Coagulation Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Global Market Analysis By Test Type (USD MN)
  • Prothrombin Time (PT) Market Sales By Geography (USD MN)
  • Activated Partial Thromboplastin Clotting Time (APTT) Market Sales By Geography (USD MN)
  • Thrombin Time (TT) Market Sales By Geography (USD MN)
  • Activated Clotting Time (ACT) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Hospitals and Clinics Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114528

The global demand for Coagulation Testing Market is presumed to reach the market size of nearly USD 5.23 Billion by 2032 from USD 2.82 Billion in 2023 with a CAGR of 7.11% under the study period 2024-2034.

Coagulation testing is a diagnostic process assessing the blood's clot ability. It includes various laboratory tests that measure the clotting factors, platelet function, and overall coagulation cascade. These tests help diagnose and monitor conditions such as bleeding disorders, thrombosis, and liver disease. Common tests include prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalized ratio (INR), and thrombin time (TT). Results from these tests provide valuable information to healthcare providers for managing anticoagulant therapy, evaluating bleeding risks before surgery, and diagnosing coagulation disorders, contributing to optimal patient care and treatment outcomes.

MARKET DYNAMICS

The increasing prevalence of coagulation disorders such as hemophilia, thrombophilia, and von Willebrand disease, coupled with the spurring incidence of cardiovascular diseases, diabetes, and cancer, is driving demand for coagulation testing as a critical component of disease diagnosis, monitoring, and management. As healthcare providers strive to improve patient care & outcomes, coagulation testing is crucial in assessing bleeding and clotting disorders, guiding treatment decisions, and preventing complications such as thrombosis and hemorrhage. Moreover, the future of healthcare looks promising with technological advancements, including point-of-care (POC) devices, laboratory-based analyzers, and molecular assays, that are expanding access to accurate and timely testing solutions for healthcare facilities, clinics, and laboratories worldwide.

Furthermore, the increasing adoption of personalized medicine approaches and targeted therapies drives demand for coagulation testing assays to provide rapid and precise results to guide individualized treatment strategies, driving market growth. Moreover, the growing emphasis on preventive healthcare, wellness screenings, and early intervention strategies is driving the integration of these tests into routine health assessments and wellness programs, driving market expansion. However, advancements in alternative diagnostic methods and changes in healthcare regulations may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Coagulation Testing. The growth and trends of Coagulation Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Coagulation Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Instruments
  • Consumables

By Test Type

  • Prothrombin Time (PT)
  • Activated Partial Thromboplastin Clotting Time (APTT)
  • Thrombin Time (TT)
  • Activated Clotting Time (ACT)
  • Others

By End-user

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Coagulation Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Coagulation Testing market include F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, Sysmex Corporation, Universal Biosensors Inc., HemoSonics LLC, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Horiba Ltd., Agappe Diagnostics Ltd., Medtronic, Helena Laboratories Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. COAGULATION TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Test Type
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product Type
  • 5.4. Instruments Historic and Forecast Sales By Regions
  • 5.5. Consumables Historic and Forecast Sales By Regions

6. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY TEST TYPE

  • 6.1. Overview By Test Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Test Type
  • 6.4. Prothrombin Time (PT) Historic and Forecast Sales By Regions
  • 6.5. Activated Partial Thromboplastin Clotting Time (APTT) Historic and Forecast Sales By Regions
  • 6.6. Thrombin Time (TT) Historic and Forecast Sales By Regions
  • 6.7. Activated Clotting Time (ACT) Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By End-user
  • 7.4. Hospitals and Clinics Historic and Forecast Sales By Regions
  • 7.5. Diagnostic Laboratories Historic and Forecast Sales By Regions
  • 7.6. Home Care Settings Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL COAGULATION TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE COAGULATION TESTING COMPANIES

  • 9.1. Coagulation Testing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF COAGULATION TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. F. Hoffmann-La Roche Ltd.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Abbott
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Siemens Healthineers
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Sysmex Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Universal Biosensors Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. HemoSonics LLC
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Thermo Fisher Scientific Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Randox Laboratories Ltd.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Horiba Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Agappe Diagnostics Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Medtronic
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Helena Laboratories Inc
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies